- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
7 Drugs Approved for Primary Care: Q1 2024
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
At the close of the first quarter of a new year, Patient Care Online has compiled a list of 7 new US Food and Drug Administration (FDA)-approved drugs for conditions that are often seen in primary care. Scroll through the slides below to find details on the first oral therapy indicated for treatment of eosinophilic esophagitis in persons aged 11 years and older; the first antihypertensive therapy to be approved in nearly 4 decades that delivers its blood pressure-lowering effect through a novel mechanism of action; and 5 more.
Centralizing evidence to boost efficiency across life sciences functions
May 28th 2025The life sciences industry is growing as medtech, biopharma, and investors all face an era of unprecedented innovation and potential. However, firms are also preparing as much as possible for unexpected business challenges and the likelihood of volatility. In an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. In this whitepaper from Wolters Kluwer, you will learn how centralized, unified, and coordinated resources can help organizations overcome fragmented processes and miscommunications, leading to enhanced problem-solving and collaboration, as well as improved outcomes.
